Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
Frontiers | Alzheimer's disease: a mini-review for the clinician
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
New Alzheimer's Biomarkers may Support Early Diagnosis
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
